Trial group:1 dose of trial vaccine

A Randomized, Blind, active-controlled trials to evaluate the safety and immunogenicity of Quadrivalent influenza vaccine (Split Virion) for Human use in the healthy subjects among 6-months to 3 years old

The post-marketing clinical study of Influenza vaccine(split virion)